首页 | 本学科首页   官方微博 | 高级检索  
检索        

尿胰蛋白酶抑制剂Ulinastatin 对lewis 肺癌小鼠肿瘤生长和转移的抑制作用
引用本文:刘红光,李汉贤,康颖,赵晓春,徐刚,王章强.尿胰蛋白酶抑制剂Ulinastatin 对lewis 肺癌小鼠肿瘤生长和转移的抑制作用[J].肿瘤防治研究,2005,32(1):24-26.
作者姓名:刘红光  李汉贤  康颖  赵晓春  徐刚  王章强
作者单位:421001,湖南,衡阳,南华大学附属一医院肿瘤科
摘    要: 目的 探讨尿胰蛋白酶抑制剂(U TI) 在动物模型上抗肿瘤作用。方法 选用尿胰蛋白酶抑制剂乌司他丁(Ulinastatin) , Lewis 肺癌小鼠模型;雄性C57BL/ 6 小鼠40 只,接种lewis 肿瘤细胞,分成生理盐水组(对照组) 、环磷酰胺组(CTX) 、Ulinastatin 2. 5万单位组、Ulinastatin 5 万单位组、Ulinastatin 10万单位组,各8 只,接种后第6 天,开始腹腔给药,记录皮下瘤长短径变化,做生长曲线;接种14 天后处死所有小鼠,统计皮下平均瘤重和肺转移灶个数, 使用流式细胞计分析凋亡率(AR) 增值百分比(SPF) 。结果 皮下瘤重依次为(7. 92 ±2. 52 、0. 66 ±0. 50** 、3. 47 ±1. 45、3. 08 ±0. 81**、1. 70 ±1. 05**) g ,平均肺转移灶依次为( 8. 625 ±1. 407 、1. 125 ±1. 126**、1. 625 ±1. 302** 、1. 00 ±0. 75** 、0. 625 ±0. 74**) 。CTX 组(39. 3 ±4. 8) %和Ulinastatin 10 万单位组(40. 2 ±3. 1) %的AR 值明显增加,Ulinastatin 未见SPF 值明显减少。结论 Ulinastatin 对lewis 肺癌小鼠的转移瘤生长和自发性肺转移有抑制作用。

关 键 词:尿胰蛋白酶抑制剂  乌司他丁  lewis  肺癌小鼠  血浆纤维蛋白溶酶激活剂
文章编号:1000-8578(2005)01-0024-03
收稿时间:2003-12-29
修稿时间:2004-4-8

Inhibition of Metastasis and Invasion of Lewis Lung Carcinoma by Urinary Trypsin Inhibitor
LIU Hong-guang,LI Hang-xian,KANG Ying,ZHAO Xiao-chun,XU Gang,WANG Zhang-qiang The First Affiliated Hospital of Nanhua University,Hengyang ,China.Inhibition of Metastasis and Invasion of Lewis Lung Carcinoma by Urinary Trypsin Inhibitor[J].Cancer Research on Prevention and Treatment,2005,32(1):24-26.
Authors:LIU Hong-guang  LI Hang-xian  KANG Ying  ZHAO Xiao-chun  XU Gang  WANG Zhang-qiang The First Affiliated Hospital of Nanhua University  Hengyang  China
Institution:LIU Hong-guang,LI Hang-xian,KANG Ying,ZHAO Xiao-chun,XU Gang,WANG Zhang-qiang The First Affiliated Hospital of Nanhua University,Hengyang 421001,China
Abstract:Objective  To investigate whether urinary t ryp sin inhibitor inhibit s tumor invasion and metastasis of lewis lung carcinoma mice . Methods  Subcutaneous ( s. c. ) implantation of 3LL cells (5. 0 ×106 ) in the right subcutaneous armpit of C57BL/ 6 male mice. There were forty mice divided into five groups with random. There were physiological saline group , cyclophosphamide group , U TI2. 5 ×104 u 7d group ,U TI 5. 0 ×104 u 7d group ,U TI 10. 0 ×104 u 7d group. They all started to inject at sixth day by abdominal cavity . The volume of tumors were measured at the 8th day ,10 th day ,12th day . The weight of primary tumor and lung metastasis were established by the 14 th day af ter tumor cell inoculation . Flow Cytometry was used to analyze apoptosis rate and s-phase f raction. Results  The average weight of tumor in turn were (7. 92 ±2. 52 、0. 66 ±0. 50 **、3. 47 ±1. 453 、3. 08 ±0. 81**3 3 、1. 70 ±1. 05** ) g , the average number of lung metastasis were (8. 625 ±1. 407 、1. 125 ±1. 126** 、1. 625 ±1. 302** 、1. 00 ±0. 75** 、0. 625 ±0. 74**) . The apoptosis rates of CTX (39. 3 ±4. 8) %and U TI 10. 0 ×104 u ( 40. 2 ±3. 1) % weremarkedly increased. The s2phase f ractions of U TI cannot reduce s-phase f raction. The tumor growthcurve showed in FIG. 3. Conclusion  Ulinastatin can inhibit primary tumors and lung metastasis carcinoma of Lewis mice.
Keywords:urinary trypsin inhibitor (UTI)  Ulinastatin  Lewis lung carcinoma mice  urokinase-type plasminogen activator (uPA)  
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号